Detalles de la búsqueda
1.
Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling.
Proc Natl Acad Sci U S A
; 105(20): 7147-52, 2008 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-18480265
2.
Phase I study of copper-binding agent ATN-224 in patients with advanced solid tumors.
Clin Cancer Res
; 14(22): 7526-34, 2008 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19010871
3.
Pharmacology of the novel antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2): observation of a U-shaped dose-response curve in several preclinical models of angiogenesis and tumor growth.
Clin Cancer Res
; 14(7): 2137-44, 2008 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18381955
4.
In vitro and in vivo efficacy of an anti-CD203c conjugated antibody (AGS-16C3F) in mouse models of advanced systemic mastocytosis.
Blood Adv
; 3(4): 633-643, 2019 02 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-30804017
5.
Modulation of Macropinocytosis-Mediated Internalization Decreases Ocular Toxicity of Antibody-Drug Conjugates.
Cancer Res
; 78(8): 2115-2126, 2018 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29382707
6.
Phase I Trials of Anti-ENPP3 Antibody-Drug Conjugates in Advanced Refractory Renal Cell Carcinomas.
Clin Cancer Res
; 24(18): 4399-4406, 2018 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29848572
7.
Copper binding by tetrathiomolybdate attenuates angiogenesis and tumor cell proliferation through the inhibition of superoxide dismutase 1.
Clin Cancer Res
; 12(16): 4974-82, 2006 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16914587
8.
A non-RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo.
Mol Cancer Ther
; 5(9): 2271-80, 2006 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16985061
9.
Inhibition of Megakaryocyte Differentiation by Antibody-Drug Conjugates (ADCs) is Mediated by Macropinocytosis: Implications for ADC-induced Thrombocytopenia.
Mol Cancer Ther
; 16(9): 1877-1886, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28655784
10.
A Potential Mechanism for ADC-Induced Neutropenia: Role of Neutrophils in Their Own Demise.
Mol Cancer Ther
; 16(9): 1866-1876, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28522588
11.
Synthesis and evaluation of multisubstrate bicyclic pyrimidine nucleoside inhibitors of human thymidine phosphorylase.
J Med Chem
; 49(26): 7807-15, 2006 Dec 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-17181163
12.
Inhibition of angiogenesis by cleaved high molecular weight kininogen (HKa) and HKa domain 5.
Curr Cancer Drug Targets
; 5(7): 519-28, 2005 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16305348
13.
Peptides derived from the histidine-proline domain of the histidine-proline-rich glycoprotein bind to tropomyosin and have antiangiogenic and antitumor activities.
Cancer Res
; 64(16): 5812-7, 2004 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15313924
14.
Prostate-specific membrane antigen directed selective thrombotic infarction of tumors.
Cancer Res
; 62(19): 5470-5, 2002 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12359755
15.
Histidine-proline-rich glycoprotein has potent antiangiogenic activity mediated through the histidine-proline-rich domain.
Cancer Res
; 62(18): 5344-50, 2002 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12235005
16.
AGS16F Is a Novel Antibody Drug Conjugate Directed against ENPP3 for the Treatment of Renal Cell Carcinoma.
Clin Cancer Res
; 22(8): 1989-99, 2016 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26589436
17.
Development of ASG-15ME, a Novel Antibody-Drug Conjugate Targeting SLITRK6, a New Urothelial Cancer Biomarker.
Mol Cancer Ther
; 15(6): 1301-10, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26944921
18.
Enfortumab Vedotin Antibody-Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models.
Cancer Res
; 76(10): 3003-13, 2016 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27013195
19.
The Discovery and Preclinical Development of ASG-5ME, an Antibody-Drug Conjugate Targeting SLC44A4-Positive Epithelial Tumors Including Pancreatic and Prostate Cancer.
Mol Cancer Ther
; 15(11): 2679-2687, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27550944
20.
Extracellular tropomyosin: a novel common pathway target for anti-angiogenic therapy.
Curr Cancer Drug Targets
; 4(7): 543-53, 2004 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-15578912